The Impact of Injection Location on the Efficacy of Intravesicular Onabotulinumtoxin A in Interstitial Cystitis--Phase 4

Trial Profile

The Impact of Injection Location on the Efficacy of Intravesicular Onabotulinumtoxin A in Interstitial Cystitis--Phase 4

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 09 Oct 2017

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Interstitial cystitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 Oct 2017 Planned End Date changed from 1 Aug 2017 to 1 Dec 2017.
    • 03 Oct 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Dec 2017.
    • 10 Dec 2015 Planned End Date changed from 1 Aug 2015 to 1 Aug 2017 as reported by CliniicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top